UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 25.

Schäfer, Juliane; Young, Jim; Calmy, Alexandra; Nicca, Dunja; Hasse, Barbara; Brun Del Re, Claudia; Cavassini, Matthias; Bernasconi, Enos; Schmidt-Trucksäss, Arno; Bucher, Heiner C; Swiss HIV Cohort Study (2017). High prevalence of physical inactivity among patients from the Swiss HIV cohort study. AIDS Care, 29(8):1056-1061.

Cecchinato, Valentina; Bernasconi, Enos; Speck, Roberto F; Proietti, Michele; Sauermann, Ulrike; D'Agostino, Gianluca; Danelon, Gabriela; Rezzonico Jost, Tanja; Grassi, Fabio; Raeli, Lorenzo; Schöni-Affolter, Franziska; Stahl-Hennig, Christiane; Uguccioni, Mariagrazia; Swiss HIV Cohort Study (2017). Impairment of CCR6+ and CXCR3+ th cell migration in HIV-1 infection is rescued by modulating actin polymerization. Journal of Immunology, 198(1):184-195.

Shilaih, Mohaned; Marzel, Alex; Braun, Dominique L; Scherrer, Alexandra U; Kovari, Helen; Young, Jim; Calmy, Alexandra; Darling, Katharine; Battegay, Manuel; Hoffmann, Matthias; Bernasconi, Enos; Thurnheer, Maria C; Günthard, Huldrych F; Kouyos, Roger D; Swiss HIV Cohort Study (2017). Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals. Medicine, 96(2):e5849.

Kovari, Helen; Rauch, Andri; Kouyos, Roger; Rougemont, Mathieu; Cavassini, Matthias; Schmid, Patrick; Stöckle, Marcel; Bernasconi, Enos; Weber, Rainer; Ledergerber, Bruno; Swiss HIV Cohort Study (2016). Hepatitis C infection and the risk of non-liver-related morbidity and mortality in HIV-positive persons in the Swiss HIV Cohort Study. Clinical Infectious Diseases:Epub ahead of print.

Sauter, Rafael; Huang, Ruizhu; Ledergerber, Bruno; Battegay, Manuel; Bernasconi, Enos; Cavassini, Matthias; Furrer, Hansjakob; Hoffmann, Matthias; Rougemont, Mathieu; Günthard, Huldrych F; Held, Leonhard; Swiss HIV Cohort Study (2016). CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART. Medicine, 95(42):e5094.

Salazar-Vizcaya, Luisa; Kouyos, Roger D; Zahnd, Cindy; Wandeler, Gilles; Battegay, Manuel; Darling, Katharine Elizabeth Anna; Bernasconi, Enos; Calmy, Alexandra; Vernazza, Pietro; Furrer, Hansjakob; Egger, Matthias; Keiser, Olivia; Rauch, Andri; Swiss HIV Cohort Study (2016). Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions. Hepatology, 64(6):1856-1869.

Marzel, Alex; Shilaih, Mohaned; Yang, Wan-Lin; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Braun, Dominique L; Calmy, Alexandra; Furrer, Hansjakob; Cavassini, Matthias; Battegay, Manuel; Vernazza, Pietro L; Bernasconi, Enos; Günthard, Huldrych F; Kouyos, Roger D; Swiss HIV Cohort Study (2016). HIV-1 transmission during recent infection and during treatment interruptions as major drivers of new infections in the Swiss HIV Cohort Study. Clinical Infectious Diseases, 62(1):115-122.

Swiss HIV Cohort Study; Kovari, Helen; Ledergerber, Bruno; et al (2015). High hepatic and extrahepatic mortality and low treatment uptake in HCV-coinfected persons in the Swiss HIV cohort study between 2001 and 2013. Journal of Hepatology, 63(3):573-580.

CoLaus Cohort; FIRE; Swiss HIV Cohort Study; et al; Hasse, Barbara (2015). Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population. Open Forum Infectious Diseases, 2(3):ofv108.

Yang, Wan-Lin; Kouyos, Roger; Scherrer, Alexandra U; Böni, Jürg; Shah, Cyril; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Furrer, Hansjakob; Battegay, Manuel; Cavassini, Matthias; Bernasconi, Enos; Vernazza, Pietro; Held, Leonhard; Ledergerber, Bruno; Günthard, Huldrych F; Swiss HIV Cohort Study (2015). Assessing the paradox between transmitted and acquired HIV type 1 drug resistance mutations in the Swiss HIV cohort study from 1998 to 2012. Journal of Infectious Diseases, 212(1):28-38.

Swiss HIV Cohort Study; Kouyos, R D; Hasse, B; et al (2015). Increases in condomless sex in the swiss HIV cohort study. Open Forum Infectious Diseases, 2(2):1-4.

Swiss HIV Cohort Study; Wandeler, Gilles; Schlauri, Marion; et al (2015). Incident hepatitis C virus infections in the swiss HIV cohort study: changes in treatment uptake and outcomes between 1991 and 2013. Open Forum Infectious Diseases, 2(1):ofv026.

Schäfer, J; Young, J; Bernasconi, E; Ledergerber, B; Nicca, D; Calmy, A; Cavassini, M; Furrer, H; Battegay, M; Bucher, H C; Swiss HIV Cohort Study (2015). Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort Study. HIV Medicine, 16(1):3-14.

Schmid, Patrick; Bregenzer, Andrea; Huber, Milo; Rauch, Andri; Jochum, Wolfram; Müllhaupt, Beat; Vernazza, Pietro; Opravil, Milos; Weber, Rainer; Swiss HIV Cohort Study (2015). Progression of liver fibrosis in HIV/HCV co-infection: a comparison between non-invasive assessment methods and liver biopsy. PLoS ONE, 10(9):e0138838.

Kovari, Helen; Russmann, Stefan; Ledergerber, Bruno; Müller, Daniel; Rotger, Margalida; Velli, Pablo; Cavassini, Matthias; Ambrosioni, Juan; Bregenzer, Andrea; Stöckle, Marcel; Bernasconi, Enos; Rauch, Andri; Speck, Roberto F; Swiss HIV Cohort Study (2015). Ribavirin concentrations do not predict sustained virological response in HIV/HCV-coinfected patients treated with ribavirin and pegylated interferon in the Swiss HIV Cohort Study. PLoS ONE, 10(7):e0133879.

Franceschi, S; Lise, M; Clifford, G M; Rickenbach, M; Levi, F; Maspoli, M; Bouchardy, C; Dehler, S; Jundt, G; Ess, S; Bordoni, A; Konzelmann, I; Frick, H; Dal Maso, L; Elzi, L; Furrer, H; Calmy, A; Cavassini, M; Ledergerber, B; Keiser, O; Swiss HIV Cohort Study (2010). Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. British Journal of Cancer, 103(3):416-422.

Rotger, M; Gsponer, T; Martinez, R; Taffé, P; Elzi, L; Vernazza, P; Cavassini, M; Bernasconi, E; Hirschel, B; Furrer, H; Weber, R; Ledergerber, B; Egger, M; Telenti, A; Tarr, P E; Swiss HIV Cohort Study (2010). Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals. Clinical Infectious Diseases, 51(9):1090-1098.

Alizon, S; von Wyl, V; Stadler, T; Kouyos, R D; Yerly, S; Hirschel, B; Böni, J; Shah, C; Klimkait, T; Furrer, H; Rauch, A; Vernazza, P L; Bernasconi, E; Battegay, M; Bürgisser, P; Telenti, A; Günthard, H F; Bonhoeffer, S; Swiss HIV Cohort Study (2010). Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load. PLoS Pathogens, 6(9):e1001123.

Franceschi, S; Maso, L D; Rickenbach, M; Polesel, J; Hirschel, B; Cavassini, M; Bordoni, A; Elzi, L; Ess, S; Jundt, G; Mueller, N; Clifford, G M; Swiss HIV Cohort Study (2008). Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. British Journal of Cancer, 99(5):800-804.

Nguyen, A; Calmy, A; Schiffer, V; Bernasconi, E; Battegay, M; Opravil, M; Evison, J M; Tarr, P E; Schmid, P; Perneger, T; Hirschel, B; Swiss HIV Cohort Study (2008). Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006. HIV Medicine, 9(3):142-150.

Rauch, A; Gaudieri, S; Evison, J; Nolan, D; Cavassini, M; Weber, R; James, I; Furrer, H; Swiss HIV Cohort Study (2008). Low current and nadir CD4+ T-cell counts are associated with higher hepatitis C virus RNA levels in the Swiss HIV cohort study. Antiviral Therapy, 13(3):455-460.

Rauch, A; Nolan, D; Thurnheer, C; Fux, C; Cavassini, M; Chave, J P; Opravil, M; Phillips, E; Mallal, S; Furrer, H; Swiss HIV Cohort Study (2008). Refining abacavir hypersensitivity diagnoses using a structured clinical assessment and genetic testing in the Swiss HIV Cohort Study. Antiviral Therapy, 13(8):1019-1028.

Glass, T R; De Geest, S; Hirschel, B; Battegay, M; Furrer, H; Covassini, M; Vernazza, P L; Bernasconi, E; Rickenboch, M; Weber, R; Bucher, H C; Swiss HIV Cohort Study (2008). Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. Antiviral Therapy, 13(1):77-85.

Fux, C; Rauch, A; Simcock, M; Bucher, H; Hirschel, B; Opravil, M; Vernazza, P; Cavassini, M; Bernasconi, E; Elzi, L; Furrer, H; Swiss HIV Cohort Study (2008). Tenofovir Use Is Associated with an Increase in Serum Alkaline Phosphatase in the Swiss HIV Cohort Study. Antiviral Therapy, 13:1077-1082.

von Wyl, V; Yerly, S; Böni, J; Bürgisser, P; Klimkait, T; Battegay, M; Furrer, H; Telenti, A; Hirschel, B; Vernazza, P L; Bernasconi, E; Rickenbach, M; Perrin, L; Ledergerber, B; Günthard, H F; Swiss HIV Cohort Study (2007). Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. Archives of Internal Medicine, 167(16):1782-1790.

This list was generated on Mon Jul 24 03:39:31 2017 CEST.